본문바로가기
Q
U
I
C
K

Global Innovative Partner of Vaccine and Biotech SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

Our Science & Technology

Conducting research into vaccines that will be the driving force in the life science business going forward.

The world's best vaccine factory with advanced vaccine technology.

Leading in expanding the global market through cooperation with global companies.

What’s New

  • SK bioscience News SK bioscience-Sanofi’s 21-Valent Pn...

    -U.S. FDA has reviewed the Investigational New Drug (IND) amendment for the Phase 3 clinical studies...

    More
  • News SK bioscience and Sanofi Expan...

    -Both companies sign an expanded agreement to deve...

    More
  • News SK bioscience Receives Approva...

    -SK bioscience’s first mRNA vaccine candidate is e...

    More
  • News SK bioscience Receives Approva...

    This approval paves the way for exports to the wor...

    More
  • News SK bioscience Acquires Stake i...

    SK bioscience invested USD 3 million in FinaBio, a...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products

  • SKYCovione™
  • SKYCellflu® Quadrivalent Prefilled Syringe
  • SKYZoster®
  • SKYVaricella®




PRODUCTS SKYCovione™
SKYCovione Multi Inj. image

[13494] 310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
Company Registration Number 818-86-00991

Copyright(c) SK bioscience. All Right Reserved

접근성 마크
  GO